58 related articles for article (PubMed ID: 26182826)
1. Advanced HIV Disease at Antiretroviral Therapy Initiation and Treatment Outcomes Among Children and Adolescents Compared to Adults Living With HIV in Kinshasa, Democratic Republic of the Congo.
Chabikuli ON; Ditekemena JD; Sigwadhi LN; Mulenga A; Mboyo A; Bidashimwa D; Nachega JB
J Int Assoc Provid AIDS Care; 2023; 22():23259582231221955. PubMed ID: 38146172
[No Abstract] [Full Text] [Related]
2. The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study.
Edmonds A; Yotebieng M; Lusiama J; Matumona Y; Kitetele F; Napravnik S; Cole SR; Van Rie A; Behets F
PLoS Med; 2011 Jun; 8(6):e1001044. PubMed ID: 21695087
[TBL] [Abstract][Full Text] [Related]
3. Impact of the implementation of new guidelines on the management of patients with HIV infection at an advanced HIV clinic in Kinshasa, Democratic Republic of Congo (DRC).
Mangana F; Massaquoi LD; Moudachirou R; Harrison R; Kaluangila T; Mucinya G; Ntabugi N; Van Cutsem G; Burton R; Isaakidis P
BMC Infect Dis; 2020 Oct; 20(1):734. PubMed ID: 33028245
[TBL] [Abstract][Full Text] [Related]
4. [Study of anemia in HIV positive children naive to antiretroviral treatment in Lubumbashi, Democratic Republic of Congo].
Mwadianvita CK; Ilunga EK; Djouma J; Wembonyama CW; Mutomb FM; Ekwalanga MB; Kabongo J; Mundongo H; Mupoya K; Wembonyama S; Kalenga Mwenze P; Nkoy AM
Pan Afr Med J; 2014; 17():46. PubMed ID: 25018796
[TBL] [Abstract][Full Text] [Related]
5. Feasibility Analysis of an evidence-based positive prevention intervention for youth living with HIV/AIDS in Kinshasa, Democratic Republic of the Congo.
Parker L; Maman S; Pettifor A; Chalachala JL; Edmonds A; Golin CE; Moracco K; Behets F; Sympa Study Team
AIDS Educ Prev; 2013 Apr; 25(2):135-50. PubMed ID: 23514081
[TBL] [Abstract][Full Text] [Related]
6. [Sociodemographic and semiological characteristics of ENT the sphere in patients with HIV/AIDS in Kinshasa, DR Congo].
Kawashi FN; Longo-Mbenza B; Matanda NR; Nge-Okwe A; Fuele SM
Pan Afr Med J; 2010; 7():15. PubMed ID: 21918702
[TBL] [Abstract][Full Text] [Related]
7. Decrease in late presentation for HIV care in Kinshasa, DRC, 2006-2020.
Ngongo NM; Nani-Tuma HS; Mambimbi MM; Mashi ML; Izizag BB; Ndolumingu FK; Maes N; Moutschen M; Darcis G
AIDS Res Ther; 2021 Jul; 18(1):41. PubMed ID: 34271957
[TBL] [Abstract][Full Text] [Related]
8. Type 2 diabetes in the Democratic Republic of Congo: an urgent need for a management framework.
Fina Lubaki JP; Omole OB; Francis JM
Health Promot Int; 2023 Dec; 38(6):. PubMed ID: 38039076
[TBL] [Abstract][Full Text] [Related]
9. [Epidemiological, Clinical And Therapeutic Profile Of Hiv-Infected Patients On Antiretroviral Treatment In Kisangani, Democratic Republic Of Congo].
Bassandja O; Yakusu I; Bongenya B; Kamangu E; Apalata T
Mali Med; 2022; 38(2):6-9. PubMed ID: 38506181
[TBL] [Abstract][Full Text] [Related]
10. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
11. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
Panel de expertos de GESIDA y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
[TBL] [Abstract][Full Text] [Related]
12. Simple markers for the detection of severe immunosuppression in children with HIV infection in highly resource-scarce settings: experience from the Democratic Republic of Congo.
Aketi L; Tshibassu PM; Kayembe PK; Kitetele F; Edidi S; Ekila MB; Wumba R; Lepira FB; Aloni MN
Pathog Glob Health; 2015 Sep; 109(6):300-4. PubMed ID: 26182826
[TBL] [Abstract][Full Text] [Related]
13. Mortality and associated factors after initiation of pediatric antiretroviral treatment in the Democratic Republic of the Congo.
Callens SF; Shabani N; Lusiama J; Lelo P; Kitetele F; Colebunders R; Gizlice Z; Edmonds A; Van Rie A; Behets F;
Pediatr Infect Dis J; 2009 Jan; 28(1):35-40. PubMed ID: 19057457
[TBL] [Abstract][Full Text] [Related]
14. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire.
Mukadi Y; Perriëns JH; St Louis ME; Brown C; Prignot J; Willame JC; Pouthier F; Kaboto M; Ryder RW; Portaels F
Lancet; 1993 Jul; 342(8864):143-6. PubMed ID: 8101257
[TBL] [Abstract][Full Text] [Related]
15. Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count and CD4 lymphocyte percentage in HIV-infected patients.
Campo J; Del Romero J; Castilla J; García S; Rodríguez C; Bascones A
J Oral Pathol Med; 2002 Jan; 31(1):5-10. PubMed ID: 11896816
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
